LAUNCH & PATIENT ACCESS CONCURRENT CGT investing basics: Don’t step on the commercial landmine
Friday, June 2, 2023 05:00 PM - 06:00 PM
Room 242AB
LAUNCH & PATIENT ACCESS
Concurrent
Chair
Patrick Rivers, BS, MBA, Partner / Head of Research, Aquilo Capital, USA
Speaker
Jim Faulkner, PhD, Venture Partner, Apple Tree Partners, UK
Kasia Urbanska, PhD, Senior Director, S&E, Cell Therapy, Bristol-Myers Squibb, USA
Investors have to consider many risk factors when choosing how to allocate capital in biotech, and commercial risk appears particularly prominent when focusing on cell/gene therapy. This session aims to address how investors think about defusing commercial risk in earlier stages of development and how product developers can attract capital by properly navigating these risks.
Patrick Rivers, BS, MBA, Partner / Head of Research, Aquilo Capital, USA
Speaker
Jim Faulkner, PhD, Venture Partner, Apple Tree Partners, UK
Kasia Urbanska, PhD, Senior Director, S&E, Cell Therapy, Bristol-Myers Squibb, USA
Investors have to consider many risk factors when choosing how to allocate capital in biotech, and commercial risk appears particularly prominent when focusing on cell/gene therapy. This session aims to address how investors think about defusing commercial risk in earlier stages of development and how product developers can attract capital by properly navigating these risks.